Becker's Healthcare August 21, 2024
Rylee Wilson

Two-thirds of employers surveyed by the Business Group on Health cover GLP-1 drugs to treat obesity.

The Business Group on Health, which represents large employers, published its annual survey of employers Aug. 20. The survey included 125 large businesses with a total of 17.1 million employees.

Employers surveyed projected healthcare costs will rise 7.8% on average in 2025, the highest increase in a decade. Pharmacy spending is the largest contributor to rising costs, according to the Business Group on Health.

Most employers surveyed reported being concerned or very concerned about the appropriate use or long-term cost of GLP-1 and other new weight loss drugs.

Around 1 in 5 employers surveyed said they would “implement immediately” limiting...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Employer, Insurance, Patient / Consumer, Pharma / Biotech, Survey / Study, Trends
Related Articles:
GLP-1 drug coverage for obesity making inroads with large employers: Mercer
44% of large employers cover weight loss drugs for obesity: Mercer
Weight-loss Drug Coverage Rises Among Largest US Employers, Mercer Survey Finds
Most American adults qualify for semaglutide. Will employers cover the cost?
How AI Is Reshaping Industries And Creating Tomorrow’s Job Market

Share This Article